Filing Flows › Merit Medical Systems (MMSI) › Guidance & outlook

Merit Medical Systems (MMSI) guidance and outlook

Merit Medical Systems (MMSI) raised some and lowered other parts of its guidance on Oct 29, 2026: Revenue $1.6B for FY2026; EPS +3% for FY2029; EPS $0.01 for FY2029.

Guidance and outlook

Met or beat 2 of 2 guided periods. Grey: the last range guided before the figures came out; dot: the reported figure.

Latest guidance

Metric	Period	Range	Change
Revenue	FY2026	$1.6B	reaffirmed
EPS	FY2029	+3%	reaffirmed
EPS	FY2029	$0.01	lowered

From the earnings release filed Oct 29, 2026 (8-K on EDGAR).

Merit Medical Systems' latest quarter

Merit Medical Systems, Q3 2026: revenue $416M (+8% year over year), operating margin 14.1%, net earnings $42.3M, operating cash flow $65.3M. The chart follows the revenue to costs, profit and cash.

Questions

Did Merit Medical Systems raise or lower its guidance?

Merit Medical Systems (MMSI) raised some and lowered other parts of its guidance on Oct 29, 2026: Revenue $1.6B for FY2026; EPS +3% for FY2029; EPS $0.01 for FY2029.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.